💊 Ipratropium (Ipratropium Bromide And Albuterol Sulfate)
An inhalation solution for nebulization that combines two bronchodilators, albuterol and ipratropium. It is used to treat bronchospasm associated with COPD in patients who need more than one bronchodilator. The drug and its dose are determined by your doctor or pharmacist.
In Arabic: إيبراتروبيوم (بروميد الإبراتروبيوم) مع ألبوتيرول (سلفات الألبوتيرول)✅ What it is used for
- Treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) in patients requiring more than one bronchodilator
🧪 Active ingredient
Albuterol sulfate: a relatively selective beta-2 adrenergic agonist that relaxes bronchial smooth muscle. Ipratropium bromide: an anticholinergic (muscarinic antagonist) that blocks acetylcholine and reduces bronchospasm. Together they act through two different mechanisms to maximize the response in COPD.
🌿 Benefits
- Relieves bronchospasm associated with COPD through two distinct mechanisms (sympathomimetic and anticholinergic)
📝 How to use
- Administered by inhalation via a jet nebulizer connected to an air compressor with adequate air flow, equipped with a mouthpiece or suitable face mask
- The solution does not require dilution before use
- The dose is set by your doctor or pharmacist; do not change the dose or frequency on your own
- If a previously effective regimen no longer gives the usual relief, seek medical advice immediately, as this may be a sign of worsening COPD
💊 Dosage forms
- Sterile solution for nebulization in 3 mL single-unit-dose vials, each containing 3 mg albuterol sulfate and 0.5 mg ipratropium bromide
⚠️ Common side effects
- Constipation
- Voice alterations
- Skin rash or itching (uncommon)
- Reported in the published literature: dry mouth, dizziness, headache, tremor, nervousness, palpitations, elevated heart rate, sinusitis, sore throat, back pain, upper respiratory tract infection, taste perversion, drowsiness, flushing
🚨 Serious — seek medical help
- Paradoxical bronchospasm (can be life-threatening): stop the drug immediately and seek medical help
- Immediate hypersensitivity reactions: urticaria, angioedema, rash, pruritus, oropharyngeal edema, bronchospasm, anaphylaxis
- Cardiovascular effects: changes in pulse rate and blood pressure, ECG changes
- Precipitation or worsening of narrow-angle glaucoma, acute eye pain, blurred vision, mydriasis
- Hypokalemia
- Metabolic acidosis (reported in the published literature)
⛔ Do not use if
- Hypersensitivity to any of its components
- Hypersensitivity to atropine and its derivatives
❗ Warnings & precautions
- Do not exceed the recommended dose; fatalities have been reported with excessive use of inhaled sympathomimetic amine products and with home use of nebulizers
- Use with caution in cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension
- The drug may need to be discontinued if clinically significant cardiovascular effects occur
- Safety and efficacy of additional doses or increased frequency beyond the guidelines have not been studied
- Safety and efficacy with nebulizers and compressors other than those used in the clinical study have not been established
🔄 Drug interactions
- Other anticholinergic agents: potential additive interaction; caution advised
- Other sympathomimetic (beta-adrenergic) agents: increased risk of adverse cardiovascular effects
- Beta-receptor blocking agents: they inhibit each other's effect; use with caution in hyperreactive airways, and relatively beta-1 selective agents are recommended if used
- Non-potassium sparing diuretics (loop or thiazide): ECG changes and/or hypokalemia may be acutely worsened, especially if the recommended dose is exceeded
- Monoamine oxidase inhibitors or tricyclic antidepressants (or within 2 weeks of discontinuing them): use with extreme caution because the cardiovascular action of albuterol may be potentiated
🤰 Pregnancy
Albuterol is Pregnancy Category C: it was teratogenic in mice (cleft palate) and caused cranioschisis in rabbits at high doses, and congenital anomalies (including cleft palate and limb defects) have been reported in offspring of treated patients without an established causal relationship. Ipratropium is Category B, with no teratogenicity shown in animal studies. Use during pregnancy only under your doctor's supervision.
🍼 Breastfeeding
It is not known whether the components are excreted in human milk. It is unlikely that ipratropium would reach the infant to an important extent. Because of the potential for tumorigenicity shown for albuterol in some animals, a decision should be made with your doctor whether to stop nursing or stop the drug, taking into account its importance to the mother.
🧒 Children
Safety and effectiveness in patients below 18 years of age have not been established.
👴 Older adults
62% of subjects in clinical studies were 65 or older and 19% were 75 or older; no overall differences in safety or effectiveness were observed, but greater sensitivity of some older individuals cannot be ruled out.
🌡️ Storage
Store at 20°C to 25°C (excursions permitted 15°C to 30°C). Protect from light. Keep the unit-dose vial in its protective foil pouch until time of use.
⏰ Missed dose
The label does not address missed doses. Do not double the dose; ask your doctor or pharmacist.
🆘 Overdose
Effects relate primarily to albuterol: seizures, angina, hypertension or hypotension, tachycardia up to 200 beats per minute, arrhythmia, nervousness, headache, tremor, dry mouth, palpitation, nausea, dizziness, fatigue, malaise, insomnia, and hypokalemia. Cardiac arrest and even death may be associated with abuse. Stop the drug and seek medical help immediately.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| IPRAVENT RESPIRATOR SOLUTION Ipratropium bromide 0.25 mg | BPC | 20 ML | 28 ₪ |
| NIRVIN COMPLETE Nasal Spray Ipratropium Br. Xylometazoline HCl | BPC | 10 ML | 30 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Albuterol: relatively selective beta-2 agonist that stimulates adenyl cyclase, increasing cAMP and relaxing bronchial smooth muscle. Ipratropium: quaternary ammonium muscarinic antagonist that prevents the rise in cGMP resulting from acetylcholine acting on muscarinic receptors of bronchial smooth muscle. The combination provides bronchodilation through two distinct mechanisms.
Labeled dosing
Labeled adult dose: one 3 mL vial administered 4 times per day via nebulization, with up to 2 additional 3 mL doses allowed per day if needed. Safety and efficacy of additional doses or increased frequency have not been studied. The final dose is determined by the doctor or pharmacist.
- Administer via jet nebulizer connected to an air compressor with adequate air flow, with mouthpiece or suitable face mask
- In the clinical study a Pari-LC-Plus nebulizer with a PRONEB compressor was used
- Failure of a previously effective regimen may signal worsening COPD requiring reassessment of therapy
- ECG changes reported with beta-agonists (T-wave flattening, QTc prolongation, ST depression) have unknown clinical significance
- Overdose management: discontinue the drug with symptomatic therapy; a cardioselective beta-blocker may be considered with caution given bronchospasm risk; insufficient evidence on benefit of dialysis
🎓 Key points for students
- Combination of an anticholinergic bronchodilator (ipratropium) and a beta-2 agonist (albuterol) giving bronchodilation via two different mechanisms
- Indication: bronchospasm in COPD when more than one bronchodilator is needed
- Contraindications: hypersensitivity to components or to atropine and derivatives
- Key warnings: paradoxical bronchospasm, excessive dosing, cardiovascular effects, immediate hypersensitivity
- Important interactions: beta-blockers, non-potassium-sparing diuretics, MAOIs and tricyclic antidepressants, other anticholinergics and sympathomimetics
- Pregnancy: albuterol Category C, ipratropium Category B
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is this medicine used for?
It is used to treat bronchospasm associated with COPD in patients who need more than one bronchodilator.
How is it used?
It is inhaled through a jet nebulizer connected to an air compressor, without dilution. The dose and frequency are set by your doctor or pharmacist and should not be exceeded.
What should I do if it stops giving the usual relief?
Seek medical advice immediately, as this may be a sign of worsening COPD requiring reassessment of treatment.
What are the main side effects?
Reported effects include constipation, voice changes, dry mouth, headache, tremor, and palpitations. Serious symptoms such as sudden breathing difficulty after a dose, facial swelling, or eye pain need immediate medical attention.
Is it suitable for children?
Safety and effectiveness in patients under 18 years have not been established.
Can it be used in pregnancy or breastfeeding?
Consult your doctor first; there are cautionary data for albuterol in pregnancy, and it is not known whether the components pass into breast milk.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-07), simplified. Updated: 2026-11-16.